MYC and breast carcinoma: Previous studies have shown that the transcription factor c‐Myc is the target of bromodomain proteins.44, 45 Furthermore, FBW7 controls proteasome‐mediated degradation of c‐Myc.46, 47 Thus, c‐Myc may also be involved in FBW7‐mediated BETi resistance in breast cancer.